Bibliografía del artículo
1. MacMahon S, Peto R, Cutler J, Collin R, Sorlie P, Neaton J, et al. Blood pressure, stroke and coronary heart disease. Part I. Prolonged differences in blood pressure: Prospective observational studies for the regression dilution bias. Lancet 335:765-774, 1990.
2. Collin R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and coronary heart disease. Br Med Bull 50:272-298, 1994.
3. Members of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The seventh report of the join National Committee [JNC VII].
4. Lloyd-James DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure. The Framingham Heart Study. Circulation 106:3068-3072, 2002.
5. Kannel WB, Belanger AJ. Epidemiology of heart failure Am Heart J 121:951-957, 1991.
6. Neaton JD, Wenworth D. Serum cholesterol, blood pressure, cigarette smoking and death for coronary artery disease: overall finding and differences by age for 316.099 white men: Multiple Risk Factor Intervention Trial [MRFIT]. Arch Int Med 152:56-64, 1992.
7. Maron DJ, Ridker PM, Thomsom AP. Risk factor and prevention of coronary heart disease. In Hurst`s: The Heart; 1998 [Ninth Edition]. McGraw-Hill Ed. pp. 1175-1196.
8. Loren BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection and prognosis. Circulation 102:470-9, 2000.
9. Devereaux RB, de Simone G, Ganau A, Roman MJ. Left ventricular hypertrophy and geometric remodelling in hypertension: stimuli, functional consequences and prognostic implications. J Hypertens 12[Suppl]:S117-S127, 1994.
10. Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geometry. JAMA 226:231-236, 1991.
11. De Simone, Devereux RB, Roman MJ, Aldermen MH, Laragh JH. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 23:600-606, 1994.
12. Van Hooft IM, Grobbee, Waal-Manning HJ, Hofman A. Hemodynamic characteristics of the early phase of primary hypertension: the Dutch Hypertension and Offspring Study. Circulation 87:1100-6, 1993.
13. Frohlich ED, Tarazi RC. Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol 44:959-963, 1979.
14. Henry RMA, Kamp O, Konstense PJ et al. Left ventricular mass increases with deteriorating glucose tolerance, especially in women: independence of increased arterial stiffness or decreased flow mediated dilatation. Diabetes Care 27:522-8, 2004.
15. Kuperstein R, Hanly P, Niroumand M, Sasson Z. The importance of age and obesity on the relation between diabetes and left ventricular mass. J Am Coll Cardiol 37:1957-62, 2001.
16. Nielsen FS, Ali S, Rossing P et al. Left ventricular hypertrophy in non-insulin-dependent diabetic patients with and without nephropathy. Diabet Med 14:538-46, 1997.
17. Sampson MJ, Denver E, Foyle WJ, Dawson D, Pinkney J, Yudkin JS. Association between left ventricular hypertrophy and erythrocyte sodium-lithium exchange in normotensive subjects with and without NIDDM. Diabetologia 38:454-460, 1995.
18. Canessa M, Adragna N, Solomon HS, Connolly TM, Tostesson DC. Increased sodium-lithium countertransport in red cells of patients with essential hypertension. New Eng J Med 302:772-6, 1980.
19. Mangili R, Bending JJ, Scott G, Li LK, Grupta, Viberti GC. . Increased sodium-lithium countertransport in red cells of patients with insulin-dependent diabetes mellitus with nephropathy. New Eng J Med 318:146-150, 1988.
20. Krolewski AS Canessa M, Warran JH, et al. Prediosposition to hypertension and susceptibility to renal disease in insulin dependent diabetes mellitus. New Eng J Med 318:140-5, 1988.
21. Ruiz-Gutierrez V, Stiefel P, Villar J, García-Donas MA, Acosta D, Carneado J. Cell membrane fatty acid composition in Type 1 [insulin-dependent] diabetic patients: relationship with sodium transport abnormalities and metabolic control. Diabetologia 36:850-6, 1993.
22. Muriana FJG, Montilla C, Stiefel P, Villar J, Ruiz-Gutierrez V. The rate of transbilayer movement of erythrocyte membrane cholesterol is correlated with sodium -lithium countertransport. Life Science 59[23]:1945-1949, 1996.
23. Villar J, Montilla C, Muñiz O, Muriana FJG, Stiefel P, Ruiz Gutierrez V, Carneado J. Erythrocyte Na+ -Li+ countertransport in essential hypertension: correlation with membrane lipids levels. J Hypertens 14:969-973, 1996.
24. Stiefel P, Ruiz-Gutierrez V, Gajón E, Acosta D, García-Donas MA, Madrazo J, Villar J, Carneado J. Sodium transport kinetics, cell membrane lipid composition, neural conduction and metabolic control in type 1 diabetic patients. Ann Nutr Metab 43:113-120, 1999.
25. Sato A, Tarnow L, Parving HH. Increased left ventricular mass in normotensive type 1 diabetic patients with nephropathy. Diabetes Care 21:1534-9, 1998.
26. Samsom MJ, Chamber J, Spirings D, Drury PL. Intraventricular septal hypertrophy in type 1 diabetic patients with microalbuminuria or early proteinuria. Diabet Med 7(2): 126-31, 1990.
27. Aepfelbacher FC, Yeon SB, Weinrauch LA, Délia J, Burger AJ. Improved glycemic control induces regression of left ventricular mass in patients with type 1 diabetes mellitus. Int J Cardiol 94(1): 47-51, 2004.
28. Kozac-Barany A, Jokinen E, Kero P, Tuominen J, Ronnemaa T, Valimaki I. Impaired left ventricular diastolic function in newborn infants of mothers with pregestational or gestational diabetes with good glycemic control. Early Hum Dev 77:13-22, 2004.
29. Urbina EM, Giddins SS, Bao W, Elkasanaby A Berenson GS. Association of fasting blood sugar level, insulin level, and obesity with left ventricular mass in children and adolescents of the Bogalusa Heart Study. Am Heart J 138:122-7, 1999.
30. Avignon A, du Cailar G, Ribstein J, Monniere L, Minram A. Left ventricular mass in the obese: influence of lean body mass. Arch Mal Coeur 90:1043-1046, 1997.
31. Grossman E, Shemesh J, Shamiss A, Thaler M, Carroll J, Rosenthal T. Left ventricular mass in diabetes-hypertension. Arch Int Med 152:1001-1004, 1992.
32. Felicio JS, Ferreira SRG, Plavnik FL, Moisés V, Kholmann O, Ribeiro AB, Zanella MT. Effect of blood glucose on left ventricular mass in patients with hypertension and type 2 diabetes mellitus. Am J Hypertens 13:1149-1154, 2000.
33. Watanabe K, Sekiya M, Tsuruoka T, Funada J, Kameoka H. Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension. J. Hypertens 17:1153-1160, 1999.
34. Miyazato J Horio T, Takishita S Kawano Y. Fasting plasma glucose is an independent determinant of left ventricular diastolic dysfunction in nondiabeteic patients wit treated hypertension. Hypertens Res 25:403-9, 2002.
35. De Fronzo RA, Tobin JB, Andres R. Glucose clamp technique: a method for quantifying insulin resistance. Am J Physiol 237:E214-223, 1979.
36. Godsland IF, Stevenson JC. Insulin resistance: syndrome or tendency. Lancet 346:100-103, 1995.
37. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal mode method and the euglycemic glucose clamp. J Clin Invest 79:790-800, 1987.
38. Buccolo RJ, Bergman RN, Marsh DJ, Yates FE. Dynamics of glucose autoregulation in the isolated blood-perfused canini liver. Am J Pphysiol 227:209-217, 1974.
39. Baron AD, Kolterman OG, Bell J, Mandarino LJ, Olefsky JM. Rates of non-insulin-mediated glucose uptake are elevated in type II diabetic subjects. J Clin Invest 76:1782-1788, 1985.
40. Ader M, Pacini G, Yang YJ, Bergman RN. Importance of glucose per se to intravenous glucose tolerance: comparison of the minimal model prediction with direct measurements. Diabetes 34:1092-110, 1985.
41. Stiefel P, Miranda ML, Rodriguez-Puras MJ, García-Morillo JS, Carneado J, Pamies, Villar J. Glucose effectiveness is strongly related to left ventricular mass in subjects with stage 1 hypertension or high-normal blood pressure. Am J Hypertens 17:146-153, 2004.
42. Araujo-Villar D, García-Estevez DA, Cabezas-Cerrato J. Insulin sensitivity, glucose effectiveness, and insulin secretion in non-diabetic offspring of patients with non-insulin-dependent diabetes mellitus: A cross-sectional study. Metabolism 48:978-983, 1999.